Validation and Compliance of a Home Monitoring Device in Pregnancy: Microlife WatchBP Home

To assess the accuracy and patient compliance in using a novel home blood pressure monitoring device in high-risk pregnancy.

The device achieved a mean difference ± SD of 0.4 ± 7.3/ −0.4 ± 5.5 mmHg (pregnancy) and −2.6 ± 7.0/0.8 ± 4.4 mmHg (preeclampsia) for systolic/ diastolic pressure. Eighty-one percent of women did at least 6 measurements/day and all women did at least 2 measurements/week.

The Microlife WatchBP Home is accurate for use in pregnancy and increases surveillance in compliant patients.

Download full abstract